.

Deeper Knowledge, Faster

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Set up watchlists for daily email updates

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Citi
Chubb
Chinese Patent Office
Queensland Health
Boehringer Ingelheim
Novartis
Mallinckrodt
Express Scripts
Colorcon
Baxter

Generated: June 24, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 075153

« Back to Dashboard
NDA 075153 describes PSEUDOEPHEDRINE HYDROCHLORIDE, which is a drug marketed by Aurobindo Pharma Ltd, Sun Pharm Inds Ltd, L Perrigo Co, Cent Pharms, Graham Dm, Kv Pharm, and Sandoz, and is included in eight NDAs. It is available from thirty-three suppliers. Additional details are available on the PSEUDOEPHEDRINE HYDROCHLORIDE profile page.

The generic ingredient in PSEUDOEPHEDRINE HYDROCHLORIDE is pseudoephedrine hydrochloride; triprolidine hydrochloride. There are forty-nine drug master file entries for this compound. Additional details are available on the pseudoephedrine hydrochloride; triprolidine hydrochloride profile page.

Summary for NDA: 075153

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 075153

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PSEUDOEPHEDRINE HYDROCHLORIDE
pseudoephedrine hydrochloride
TABLET, EXTENDED RELEASE;ORAL 075153 ANDA L Perrigo Company 0113-0054 0113-0054-52 1 BLISTER PACK in 1 CARTON (0113-0054-52) > 10 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK
PSEUDOEPHEDRINE HYDROCHLORIDE
pseudoephedrine hydrochloride
TABLET, EXTENDED RELEASE;ORAL 075153 ANDA L Perrigo Company 0113-2054 0113-2054-60 2 BLISTER PACK in 1 CARTON (0113-2054-60) > 10 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK

Summary for product number 001

Active Rx/OTC/Discontinued:OTCDosage:TABLET, EXTENDED RELEASE;ORALStrength120MG
Approval Date:Feb 26, 1999TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cipla
Dow
AstraZeneca
Federal Trade Commission
Daiichi Sankyo
McKinsey
Cerilliant
US Army
Express Scripts
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot